UnitedHealth Group isn’t in the crosshairs just for its Change Healthcare ransomware attack fallout. The Oregon Health Authority is reviewing UHG’s $3.3 billion acquisition of Baton Rouge, La.-based Amedisys Inc., according to press reports. And the Department of Justice is considering filing suit to block the sale under antitrust rules, seekingalpha.com reports.
The latter may not be a surprise, considering the DOJ and Federal Trade Commission’s recent aggressive policy changes on antitrust matters (see story, p. x) and the rumor of a more general DOJ antitrust probe of UHG last month (see HHHW by AAPC, Vol. XXXIII, No. 8).